---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-015584"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2025-06-18T23:59:59+00:00"
generated_at: "2026-05-19T03:27:30.337300+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Biofrontera shareholders approve doubling authorized shares to 70M at annual meeting

## Summary
- Heikki Lanckriet elected Class I director with 4,565,450 votes for, 329,105 withheld.
- Amendment to increase authorized common shares from 35M to 70M approved (5,499,898 for, 837,939 against).
- Adjournment proposal approved (5,716,131 for) to allow further solicitation if needed.
- Ratification of CBIZ CPAs P.C. as auditor for FY2025 approved (6,144,222 for).

## SEC filing metadata
- accession: 0001641172-25-015584
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2025-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000164117225015584/0001641172-25-015584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000164117225015584/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-015584
- JSON: https://secwatch.observer/filing/0001641172-25-015584.json
- Plain text: https://secwatch.observer/filing/0001641172-25-015584.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.